Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)
Ratios

Relay Therapeutics (RLAY) Receivables - Other (2020 - 2023)

Relay Therapeutics (RLAY) has disclosed Receivables - Other for 4 consecutive years, with $4.9 million as the latest value for Q1 2023.

  • Quarterly Receivables - Other rose 4.77% to $4.9 million in Q1 2023 from the year-ago period, while the trailing twelve-month figure was $4.9 million through Mar 2023, up 4.77% year-over-year, with the annual reading at $4.9 million for FY2022, 8.29% up from the prior year.
  • Receivables - Other for Q1 2023 was $4.9 million at Relay Therapeutics, roughly flat from $4.9 million in the prior quarter.
  • The five-year high for Receivables - Other was $8.6 million in Q1 2021, with the low at $4.2 million in Q2 2021.
  • Average Receivables - Other over 4 years is $5.3 million, with a median of $4.8 million recorded in 2022.
  • Peak annual rise in Receivables - Other hit 14.7% in 2022, while the deepest fall reached 45.65% in 2022.
  • Over 4 years, Receivables - Other stood at $7.7 million in 2020, then crashed by 40.72% to $4.5 million in 2021, then rose by 8.29% to $4.9 million in 2022, then decreased by 0.26% to $4.9 million in 2023.
  • According to Business Quant data, Receivables - Other over the past three periods came in at $4.9 million, $4.9 million, and $4.9 million for Q1 2023, Q4 2022, and Q3 2022 respectively.